Lantern Pharma Inc

NASDAQ:LTRN   1:32:31 PM EDT
10.58
-0.83 (-7.27%)
Products

FDA Grants Lantern Pharma Additional Orphan Drug Designation For Rare Tumor Investigational Drug

Published: 08/30/2021 13:08 GMT
Lantern Pharma Inc (LTRN) - FDA Grants Lantern Pharma Additional Orphan Drug Designation for Drug Candidate Lp-184 in Glioblastoma Multiforme & Malignant Gliomas.